| An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies (NCT02431260) | Incyte Corporation | 2015-04-14 |
| A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer (NCT02391480) | AbbVie | 2015-04-14 |
| Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers. (NCT03497715) | Reckitt Benckiser Healthcare (UK) Limited | 2015-04-14 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers (NCT02432664) | Orion Corporation, Orion Pharma | 2015-04-14 |
| Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors (NCT02379416) | National Cancer Institute (NCI) | 2015-04-13 |
| Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders (NCT02324673) | INSYS Therapeutics Inc | 2015-04-13 |
| Safety of Romiplostim (Nplate®) Following UCBT (NCT02046291) | Masonic Cancer Center, University of Minnesota | 2015-04-10 |
| A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations (NCT02418000) | Spirita Oncology, LLC | 2015-04-10 |
| Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer (NCT02389751) | M.D. Anderson Cancer Center | 2015-04-10 |
| Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT02299505) | Novartis Pharmaceuticals | 2015-04-09 |
| A Study of VLX1570 and Dexamethasone in Myeloma Patients (NCT02372240) | Vivolux AB | 2015-04-08 |
| A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease (NCT02367183) | Celgene | 2015-04-08 |
| Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer (NCT02298959) | National Cancer Institute (NCI) | 2015-04-08 |
| First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (NCT02335814) | RAPT Therapeutics, Inc. | 2015-04-08 |
| Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus (NCT03059719) | PegBio Co., Ltd. | 2015-04-08 |
| A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors (NCT02442414) | Sihuan Pharmaceutical Holdings Group Ltd. | 2015-04-07 |
| Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy (NCT02208167) | University of North Carolina, Chapel Hill | 2015-04-07 |
| PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (NCT02417688) | Washington University School of Medicine | 2015-04-05 |
| Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer (NCT02225405) | M.D. Anderson Cancer Center | 2015-04-03 |
| An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA) (NCT02268552) | Novartis Pharmaceuticals | 2015-04-02 |
| Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies (NCT02270788) | St. Jude Children's Research Hospital | 2015-04-02 |
| Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (NCT02203903) | Catherine Bollard | 2015-04-02 |
| A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication (NCT02446561) | Mundipharma Research Limited | 2015-04-01 |
| Taste Evaluation of Different Liquid Formulations With Eliglustat (NCT02422654) | Genzyme, a Sanofi Company | 2015-04-01 |
| Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia (NCT02996812) | Tracey McLaughlin | 2015-04-01 |
| Regorafenib Phase I Study in Mainland Chinese Patients (NCT02398513) | Bayer | 2015-04-01 |
| An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia (NCT02077361) | University of Alberta | 2015-04-01 |
| Health Evaluation in African Americans Using RAS Therapy (NCT02471833) | Emory University | 2015-04-01 |
| Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B (NCT02811731) | Chong Kun Dang Pharmaceutical | 2015-04-01 |
| Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1 (NCT02390466) | InnaVirVax | 2015-04-01 |
| 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. (NCT02088645) | University Hospital, Basel, Switzerland | 2015-04-01 |
| Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis (NCT02499315) | Amgen | 2015-04-01 |
| Fatty Liver Disease in Obese Children (NCT02117700) | Nemours Children's Clinic | 2015-04-01 |
| T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies (NCT02457650) | Shenzhen Second People's Hospital | 2015-04-01 |
| Transcutaneous Electrical Nerve Stimulation Post-thoracic Surgery in a Intensive Care Unit (NCT02438241) | Irmandade Santa Casa de Misericórdia de Porto Alegre | 2015-04-01 |
| TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus (NCT02430870) | Takeda | 2015-04-01 |
| Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome (NCT02616796) | Stanford University | 2015-04-01 |
| Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers (NCT02469987) | Mylan Inc. | 2015-04-01 |
| Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL (NCT02419560) | Craig Portell, MD | 2015-04-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a) (NCT02414594) | Ionis Pharmaceuticals, Inc. | 2015-04-01 |
| Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) (NCT02418481) | Fuda Cancer Hospital, Guangzhou | 2015-04-01 |
| Development and Evaluation of a Cognitive Enhancement Product Made From Selected Thai Herbs for Menopausal Women (NCT02567760) | Khon Kaen University | 2015-04-01 |
| Roniciclib Mass Balance Study (NCT02390154) | Bayer | 2015-04-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects (NCT02429102) | Tanabe Pharma Corporation | 2015-04-01 |
| A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC (NCT02374645) | Hutchison Medipharma Limited | 2015-04-01 |
| Acute Treatment of Migraine Using the CEFALY Device (NCT02411513) | Cefaly Technology | 2015-04-01 |
| Wound Healing Process in Diabetic Neuropathy and Diabetic Neuroischemia (NCT02378909) | University of Manchester | 2015-04-01 |
| Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine (NCT02415907) | H. Lundbeck A/S | 2015-04-01 |
| Experimental Falciparum Transmission to Anopheles (NCT02431637) | Medicines for Malaria Venture | 2015-04-01 |
| A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD) (NCT02433093) | Hoffmann-La Roche | 2015-04-01 |
| Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA-Related Cancers (NCT02396433) | The University of Texas Health Science Center at San Antonio | 2015-04-01 |
| Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin (NCT02235233) | University of North Carolina, Chapel Hill | 2015-04-01 |
| Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy (NCT02412462) | Alethia Biotherapeutics | 2015-04-01 |
| Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases (NCT02385136) | Zhejiang Cancer Hospital | 2015-04-01 |
| Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults (NCT02921659) | University of Colorado, Boulder | 2015-04-01 |
| ADC-1013 First-in-Human Study (NCT02379741) | Alligator Bioscience AB | 2015-04-01 |
| Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome (NCT02262338) | ArmaGen, Inc | 2015-04-01 |
| Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer (NCT02425735) | Fuda Cancer Hospital, Guangzhou | 2015-04-01 |
| SBRT Pre-operatively for Pancreatic Cancer (NCT02308722) | University of Oxford | 2015-04-01 |
| A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors (NCT02432326) | Sumitomo Pharma America, Inc. | 2015-04-01 |
| Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects (NCT02340988) | Melinta Therapeutics, Inc. | 2015-04-01 |
| First-in-Human Single Ascending Dose of SHR0302 (NCT02423538) | Jiangsu HengRui Medicine Co., Ltd. | 2015-04-01 |
| A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy (NCT02422485) | Adam Boxer | 2015-04-01 |
| Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study (NCT02401269) | University of Pittsburgh | 2015-04-01 |
| Phase 1 Single Subcutaneous Dose Study of MLN1202 (NCT02426021) | Takeda | 2015-04-01 |
| Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. (NCT02417844) | Boehringer Ingelheim | 2015-04-01 |
| Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris (NCT04206631) | Indonesia University | 2015-04-01 |
| Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine (NCT02458326) | Universidade Federal de Pernambuco | 2015-04-01 |
| Acid-Base Compensation in Chronic Kidney Disease (NCT02427594) | Duke University | 2015-04-01 |
| DFMO in Children With Type 1 Diabetes (NCT02384889) | Indiana University | 2015-04-01 |
| A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma (NCT02413827) | Celldex Therapeutics | 2015-04-01 |
| A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 (NCT02995239) | HK inno.N Corporation | 2015-04-01 |
| Practical Approaches to Exercise in Moms (NCT02516865) | Maxine Mendelson | 2015-04-01 |
| A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors (NCT02428712) | Fore Biotherapeutics | 2015-04-01 |
| A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants (NCT02376400) | Crucell Holland BV | 2015-04-01 |
| A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants (NCT02398591) | Janssen Sciences Ireland UC | 2015-04-01 |
| Cough According to Stimulus Type in PD (NCT02390089) | University of Florida | 2015-04-01 |
| Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) (NCT02450838) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-04-01 |
| A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers (NCT02406989) | MingSight Pharmaceuticals Pty Limited | 2015-04-01 |
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours (NCT02423239) | e-Therapeutics PLC | 2015-04-01 |
| Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women (NCT02434640) | Bayer | 2015-04-01 |
| A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa) (NCT02486432) | NeuroDerm Ltd. | 2015-04-01 |
| University of Alabama at Birmingham (UAB) Adult CBD Program (NCT02700412) | University of Alabama at Birmingham | 2015-04-01 |
| Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects (NCT02412449) | Akebia Therapeutics | 2015-04-01 |
| Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects (NCT02453529) | Wockhardt | 2015-04-01 |
| A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Subjects With Schizophrenia (NCT02418819) | Pfizer | 2015-04-01 |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) (NCT02423954) | Western Regional Medical Center | 2015-04-01 |
| Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection (NCT02443935) | University of Aarhus | 2015-04-01 |
| Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104 (NCT02800811) | OSE Immunotherapeutics | 2015-04-01 |
| A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients (NCT02388594) | University of Pennsylvania | 2015-04-01 |
| Role of Stem Cells in Improving Implantation Rates in ICSI Patients (NCT01649752) | Kasr El Aini Hospital | 2015-04-01 |
| Multiple Treatments for Ebola Virus Disease (EVD) (NCT02380625) | Clinical Research Management, Inc. | 2015-04-01 |
| Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis (NCT02342691) | The Forsyth Institute | 2015-04-01 |
| Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs (NCT02332889) | University of Louisville | 2015-04-01 |
| Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma (NCT02291848) | Baylor College of Medicine | 2015-04-01 |
| Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma (NCT02406170) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-04-01 |
| Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets (NCT02387580) | Medicines for Malaria Venture | 2015-04-01 |
| The StepSmart Project: A Pedometer Based Phased Intervention to Encourage Physical Activity in Schools (NCT02455986) | Queen's University, Belfast | 2015-04-01 |
| Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions (NCT02941731) | Hanmi Pharmaceutical Company Limited | 2015-04-01 |
| A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load (NCT02391077) | Ministry of Health, Rwanda | 2015-04-01 |